Protalix BioTherapeutics, Inc.PLXNYSE
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 63 | 38↓39.0% | 48↑24.2% | 65↑37.5% | 53↓18.5% |
| Gross Profit | 52 | 22↓57.7% | 28↑27.5% | 43↑51.6% | 29↓31.6% |
| Operating Income | 3 | -20↓855.1% | -13↑36.4% | 10↑180.4% | 4↓62.6% |
| Net Income | -7 | -28↓322.8% | -15↑45.9% | 8↑155.7% | 3↓64.7% |
| EBITDA | 4 | -19↓525.7% | -11↑43.1% | 13↑220.0% | 7↓49.6% |
| EPS Diluted | -0.22 | -0.62↓181.8% | -0.31↑50.0% | 0.10↑132.3% | 0.04↓63.4% |